159 related articles for article (PubMed ID: 31261510)
21. Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer.
Vyfhuis MAL; Burrows WM; Bhooshan N; Suntharalingam M; Donahue JM; Feliciano J; Badiyan S; Nichols EM; Edelman MJ; Carr SR; Friedberg J; Henry G; Stewart S; Sachdeva A; Pickering EM; Simone CB; Feigenberg SJ; Mohindra P
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):445-452. PubMed ID: 29559292
[TBL] [Abstract][Full Text] [Related]
22. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
Amini A; Correa AM; Komaki R; Chang JY; Tsao AS; Roth JA; Swisher SG; Rice DC; Vaporciyan AA; Lin SH
Ann Thorac Surg; 2012 Sep; 94(3):914-20. PubMed ID: 22819472
[TBL] [Abstract][Full Text] [Related]
23. Effect of thoracic surgery regionalization on long-term survival after lung cancer resection.
Ely S; Jiang SF; Dominguez DA; Patel AR; Ashiku SK; Velotta JB
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):769-777. PubMed ID: 33934900
[TBL] [Abstract][Full Text] [Related]
24. Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy.
Rossi E; Noberasco C; Picchi M; Stefano MD; Rossi A; Nurra L; Ventura L
J Altern Complement Med; 2018; 24(9-10):933-941. PubMed ID: 30247968
[TBL] [Abstract][Full Text] [Related]
25. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer.
Wang NF; Tang HM; Liu FL; Hong QY
Chin Med J (Engl); 2020 Apr; 133(7):786-791. PubMed ID: 32195672
[TBL] [Abstract][Full Text] [Related]
26. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
[TBL] [Abstract][Full Text] [Related]
27. Assessment of lung cancer risk factors and mortality in Qatar: A case series study.
Abdel-Salam AG; Mollazehi M; Bandyopadhyay D; Malki AM; Shi Z; Zayed H
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1302. PubMed ID: 33026195
[TBL] [Abstract][Full Text] [Related]
28. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
[TBL] [Abstract][Full Text] [Related]
29. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B
Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393
[TBL] [Abstract][Full Text] [Related]
30. A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.
Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L
Integr Cancer Ther; 2018 Sep; 17(3):902-911. PubMed ID: 29775121
[TBL] [Abstract][Full Text] [Related]
31. Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study.
Samuels N; Cohen N; Katz D; Ben-Arye E
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10143-10148. PubMed ID: 37264264
[TBL] [Abstract][Full Text] [Related]
32. Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.
Ma L; Qiu B; Zhang J; Li QW; Wang B; Zhang XH; Qiang MY; Chen ZL; Guo SP; Liu H
Chin J Cancer; 2017 Dec; 36(1):93. PubMed ID: 29228994
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.
McCulloch M; Broffman M; van der Laan M; Hubbard A; Kushi L; Kramer A; Gao J; Colford JM
Integr Cancer Ther; 2011 Sep; 10(3):260-79. PubMed ID: 21824893
[TBL] [Abstract][Full Text] [Related]
34. Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience.
Lee SH; Choi WC; Yoon SW
Integr Cancer Ther; 2009 Jun; 8(2):148-52. PubMed ID: 19679623
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
36. Does granulocyte colony-stimulating factor affect survival in patients with advanced non-small cell lung cancer?
Kasymjanova G; Kreisman H; Correa JA; Dajczman E; Small D
J Thorac Oncol; 2006 Jul; 1(6):564-70. PubMed ID: 17409918
[TBL] [Abstract][Full Text] [Related]
37. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
38. Chest radiography surveillance for lung cancer: Results from a National Health Insurance database in South Korea.
Koo HJ; Choi CM; Park S; Lee HN; Oh DK; Ji WJ; Kim S; Kim MY
Lung Cancer; 2019 Feb; 128():120-126. PubMed ID: 30642443
[TBL] [Abstract][Full Text] [Related]
39. Association of institutional transition of cancer care with mortality in elderly patients with lung cancer: a retrospective cohort study using national claim data.
Han KT; Chang J; Choi DW; Kim S; Kim DJ; Chang YJ; Kim SJ
BMC Cancer; 2022 Apr; 22(1):452. PubMed ID: 35468762
[TBL] [Abstract][Full Text] [Related]
40. Rhus verniciflua stokes against advanced cancer: a perspective from the Korean Integrative Cancer Center.
Choi W; Jung H; Kim K; Lee S; Yoon S; Park J; Kim S; Cheon S; Eo W; Lee S
J Biomed Biotechnol; 2012; 2012():874276. PubMed ID: 22174564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
